Skip Navigation

This Article
Right arrow Print PDF (2869K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (76)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Brand, N. J.
Right arrow Articles by Chambon, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brand, N. J.
Right arrow Articles by Chambon, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1990, Vol. 18, No. 23 6799-6806
© 1990


Articles

Characterization of a functional promoter for the human retinoic acid receptor-alpha (hRAR-{alpha})

Nigel J. Brand+, Martin Petkovich§ and Pierre Chambon*

Laboratoire de Gënëtique Molëculaire des Eucaryotes du CNRS, Unitë de Biologie Molëculaire et de Gënie Gënëtique de I'INSERM, Institut de Chimie Biologique, Facultë de Mëdecine 11, rue Humann, 67085 Strasbourg Cëdex, France

* To whom correspondence should be addressed

Received September 27, 1990. Accepted October 30, 1990.

The three retinoic acid receptors RAR-{alpha}, ß and {gamma} are thought to mediate the effects of RA in vivo. We have determined here the exon organisation in the 5' region of the human RAR-{alpha} (hRAR-{alpha}) gene, and have identified its promoter. This promoter drives the expression of promoterless ß-globin or CAT reporter genes when transfected into HeLa, Cos-1 or mouse embryonal carcinoma (EC) P19.6 cells in culture. There are no TATA or CCAAT-box elements In this promoter, which appears to belong to the class of promoters made up of an initiator element preceded by several putative binding sites for the transcription factor Sp1. In addition, the hRAR-{alpha} promoter region contains a number of sequences that are similar to known enhancer elements. Notably, the hRAR-{alpha} promoter contains a sequence identical to a binding site for the Krox-20 transcription factors, a zinc finger-containing protein which is thought to play a role in the early development of the mouse central nervous system.


+Present addresse: Department of Cardiothoracic Surgery, National Heart and Lung Institute, London, SW3 6LY, UK

§Present addresse: Cancer Research Laboratory, Queens University, Kingston, Ontario K7L 3N6, Canada


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
P. Germain, P. Chambon, G. Eichele, R. M. Evans, M. A. Lazar, M. Leid, A. R. De Lera, R. Lotan, D. J. Mangelsdorf, and H. Gronemeyer
International Union of Pharmacology. LX. Retinoic Acid Receptors
Pharmacol. Rev., December 1, 2006; 58(4): 712 - 725.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B.-W. Gu, H. Xiong, Y. Zhou, B. Chen, L. Wang, S. Dong, Z.-Y. Yu, L.-F. Lu, M. Zhong, H.-F. Yin, et al.
Variant-type PML-RARalpha fusion transcript in acute promyelocytic leukemia: Use of a cryptic coding sequence from intron 2 of the RARalpha gene and identification of a new clinical subtype resistant to retinoic acid therapy
PNAS, May 28, 2002; 99(11): 7640 - 7645.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Parrado, G. Despouy, R. Kraiba, C. L. Pogam, S. Dupas, M. Choquette, M. Robledo, J. Larghero, H. Bui, I. L. Gall, et al.
Retinoic acid receptor {alpha}1 variants, RAR{alpha}1{Delta}B and RAR{alpha}1{Delta}BC, define a new class of nuclear receptor isoforms
Nucleic Acids Res., December 15, 2001; 29(24): 4901 - 4908.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Salto, J. M. Kindblom, C. Johansson, Z. Wang, H. Gullberg, K. Nordstrom, A. Mansen, C. Ohlsson, P. Thoren, D. Forrest, et al.
Ablation of TR{alpha}2 and a Concomitant Overexpression of {alpha}1 Yields a Mixed Hypo- and Hyperthyroid Phenotype in Mice
Mol. Endocrinol., December 1, 2001; 15(12): 2115 - 2128.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Zou, K. B. Marschke, K. E. Arnold, E. M. Berger, P. Fitzgerald, D. E. Mais, and E. A. Allegretto
Estrogen Receptor {beta} Activates the Human Retinoic Acid Receptor {alpha}-1 Promoter in Response to Tamoxifen and Other Estrogen Receptor Antagonists, but Not in Response to Estrogen
Mol. Endocrinol., March 1, 1999; 13(3): 418 - 430.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. Jehan and H. F. DeLuca
Cloning and characterization of the mouse vitamin D receptor promoter
PNAS, September 16, 1997; 94(19): 10138 - 10143.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Scita, N. Darwiche, E. Greenwald, M. Rosenberg, K. Politi, and L. M. De Luca
Retinoic Acid Down-regulation of Fibronectin and Retinoic Acid Receptor alpha Proteins in NIH-3T3 Cells
J. Biol. Chem., March 15, 1996; 271(11): 6502 - 6508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Choudhury, R. K. Singh, N. Moniaux, T. H. El-Metwally, J.-P. Aubert, and S. K. Batra
Retinoic Acid-dependent Transforming Growth Factor-beta 2-mediated Induction of MUC4 Mucin Expression in Human Pancreatic Tumor Cells Follows Retinoic Acid Receptor-alpha Signaling Pathway
J. Biol. Chem., October 20, 2000; 275(43): 33929 - 33936.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.